This invention relates to a system and method for intermixing the contents of two separate containers that avoids discharge of the contents of the containers into the environment while maintaining sterility of the system.
Many compounds for medical use are packaged separately from diluents used to facilitate administration of the compound to a patient. These medical compounds are packaged in a variety of known pharmaceutical containers (e.g., vials) in solid (e.g., lyophilized or spray-dried) form, in liquid form, in other forms. Prior to administration of these compounds to a patient, the compounds are mixed with a variety of known diluents in order to reconstitute, dilute, and/or facilitate intravenous or subcutaneous delivery to a patient. The diluents used can contain additional active compounds, if desired. In order to maintain the sterility of both the compound and the diluent in their respective containers, it is desirable to provide a system for intermixing that is substantially closed, i.e., one that does not expose the compound or diluent to the external environment. Such exposure could negatively affect the sterility of the resulting mixture of the compound and diluent, or, in the case of hazardous compounds, could expose healthcare workers to the hazardous compound.
Systems for facilitating the safe transfer and mixing of medical compounds and diluents stored in separate containers are known. For example, a system involving packaging of a medicament and a diluent in separate containers, which may be connected to one another at the time of use for convenient, safe intermixing of the medicament and diluent in a sterile environment is currently sold by Hospira, Inc. (Lake Forest, Ill.), the owner of this application, under the trademark ADD-VANTAGE. A number of details of the ADD-VANTAGE system are disclosed in U.S. Pat. Nos. 4,757,911; 4,703,864; 4,784,658; 4,784,259; 4,948,000; 4,936,445; 5,064,059; and 5,332,399, all of which are incorporated herein by reference.
In one example of the ADD-VANTAGE system referenced above, a flexible diluent container includes a receiving port constructed to receive a medicament vial closed by a vial stopper. The receiving port is positioned at the top end of the diluent container, i.e., the end of the diluent container that is on top when the diluent container is hung for delivery of its contents to a patient. The flexible diluent container further includes a stopper removal member configured to connect to the vial stopper by engaging an undercut or shouldered recess in the exposed end of the vial stopper. Securement of the vial and the diluent container is accomplished by threadable engagement of threads that circumscribe the outside of the neck portion (which defines the vial opening) of the vial with complementary threads within the diluent container port. Additionally, ratchet teeth, which circumscribe the outside of a skirt member of the vial, engage with complementary ratchet teeth located on the interior of the diluent container port. The slopes of the ratchet teeth are such that once engagement is initiated, the vial cannot be backed out of the port without causing visible damage to the vial and/or port, thereby obviating any contamination which may be occasioned by vial-container disengagement and reengagement. In other words, the ratchet teeth are “one-way” ratchet teeth. Further, as the stoppered vial is advanced into and engaged with the port of the diluent container, the vial stopper advances onto the stopper removal member. The stopper removal member is thereby secured to the stopper such that the stopper may subsequently be pulled and removed (via manipulation of the stopper removal member) from the vial, thereby allowing intermixing of the contents of the two containers.
The flow path created as a result of activating the stopper removal member of the ADD-VANTAGE system is defined by the neck of the vial and the dimension of the flow channel defined through the port of the diluent container. The dimension of this flow path is sufficient to permit the contents of the diluent container to flow readily into and out of the vial, e.g., by “sloshing” the diluent container. By providing significant flow of fluid between the vial and the diluent container, the ADD-VANTAGE system provides quick and thorough mixing. Further, because the vial is positioned at the top end of the diluent container when the contents of the diluent container are delivered to a patient, any contents remaining in the vial will flow into the diluent container.
In the ADD-VANTAGE system, securement of the vial and diluent container, and subsequent intermixing of their respective contents, requires that the vial and the container be complementary and be manufactured to specifically connect to each other.
An example of an alternative transfer system is the add-EASE binary connector sold by B. Braun Medical, Inc. A first end of the add-EASE connector includes a structure for receiving and securing the connector to a pharmaceutical vial. The first end includes a first spike for penetrating an elastomeric stopper sealing the vial. The second end of the add-EASE connector includes a structure for receiving and securing the connector to a port of a diluent container. The second end includes a second spike for penetrating an elastomeric closure associated with the port of the diluent container. Once the add-EASE connector has been secured to both the vial and the diluent container, pressure is applied to the contents of the diluent container. This pressure results in a force being applied to a plug member positioned within the first spike, thereby moving the plug from the first spike and into the vial. Because of the relatively narrow flow channel defined by the first and second spikes of the add-EASE connector, it is necessary to pump or “milk” diluent out of the diluent container and into the vial in order to reconstitute and/or dilute the drug contained in the vial. It also is necessary to pump or “milk” the resulting diluent/drug mixture out of the vial back into the diluent container for delivery to the patient. Further, because the diluent container port is positioned at the bottom of the diluent container, i.e., at the end of the diluent container that is positioned closest to the floor when the contents of the diluent container are delivered to a patient, the dimension of the flow channel defined by the first and second spikes must remain small in order to prevent contents of the diluent container from flowing back into the vial (rather than flowing to the patient).
In light of the above-described systems and their respective characteristics, the inventors have identified a need in the art for a system for intermixing substances that uses a diluent container similar to the ADD-VANTAGE diluent container described above but does not require a dedicated, complementary vial.
Disclosed herein are various embodiments of a system and corresponding method that use a connector that allows a user (e.g., a pharmacist or other healthcare worker) to intermix at least two substances from two separate containers while maintaining sterility and preventing unwanted release of the substances into the environment. Various embodiments of the connector are also disclosed.
According to one embodiment of the system, the system includes a first container, a second container, and a connector for providing fluid communication between the first and second containers. The first container may be a medicament container such as a vial. The second container may be a diluent container such as an intravenous (IV) bag. In one example, the connector accommodates standard vials.
According to another embodiment of the system, the system includes (i) a first container (with a first substance) comprising a pierceable seal for sealing the distal end of the first container, (ii) a second container (with a second substance) comprising (a) a receiving port with a securing mechanism and (b) a removable sealing member for sealing the receiving port, and (iii) a connector for connecting the first and second containers. The connector includes (a) a body having a proximal end with a cavity for engaging the first container and a distal end with an opening and a securing mechanism that is complementary to the securing mechanism of the second container, (b) a penetrating member with a flow passageway for providing fluid communication between the containers, and (c) at least one resilient retention member within the cavity for securing the distal end of the first container. The penetrating member extends in the proximal direction from a position within the cavity, and is configured to pierce the seal of the first container.
In another embodiment, the removable sealing member of the second container prevents the first and second substances from intermixing until the removable sealing member is disengaged from the receiving port of the second container. The first and second substances may be intermixed by inverting or shaking the system after (i) the first and second containers are secured to the connector and (ii) the removable sealing member is disengaged from the receiving port of the second container.
In another embodiment, the connector also includes a removable plug located near the distal end of the connector. The removable plug seals the opening of the connector and is configured to engage the removable sealing member of the second container when the second container is connected to the connector. The removable plug may also include a recess with an undercut for engaging the removable sealing member of the second container such that the removable plug may be removed from the connector by removing the removable sealing member from the receiving port. The removable sealing member of the second container and the removable plug of the connector may prevent the first and second substances from intermixing until the removable sealing member is disengaged from the receiving port of the second container and the removable plug is disengaged from the opening of the connector.
In another embodiment, the receiving port of the connector includes complementary ratchet teeth that prevent the connector from being removed from the receiving port when the securing mechanism of the connector is engaged with securing mechanism of the second container.
In another embodiment, the at least one resilient retention member of the connector is configured to engage a shoulder of the first container and inhibit removal of the first container from the connector after a distal end of the first container is inserted a predetermined distance into the cavity. The resilient retention member may extend distally inwardly within the cavity. In one example, the connector includes at least two resilient retention fingers.
In another embodiment, the at least one resilient retention member is attached to the body of the connector via at least two tabs. After the first container is docked to the connector, removal of the first container may cause at least one of the at least two tabs to break, thereby providing a visual indication that the first container was removed and discouraging reuse of the connector.
In another embodiment, fluid communication between the first and second containers is established by externally manipulating the second container such that the removable sealing member is removed from the receiving port of the second container.
According to one embodiment of the connector, the connector comprises (i) a body including a proximal end with a cavity for engaging the first container and a distal end having an opening, (ii) a penetrating member extending in the proximal direction from a position within cavity, where a proximal end of the penetrating member is configured to pierce a seal of the first container and includes an aperture and a flow passageway that provides fluid communication from the aperture to the opening of the distal end, (iii) at least one resilient retention member for securing the first container to the connector, where the at least one resilient retention finger is positioned (a) within the cavity near the proximal end of the body and (b) laterally offset from the penetrating member, and where the at least one resilient retention member is configured to engage a shoulder of the first container, and prevent removal of the first container from the connector after a distal end of the first container is inserted a predetermined distance into the cavity, and (iv) two securing mechanisms for securing the connector to the second container. One of the securing mechanisms comprises threads circumscribing the exterior of the opening and the other securing mechanism comprises ratchet teeth configured to allow engagement but not disengagement of threads on a complementary securing mechanism of the second container.
In another embodiment, the connector does not prevent fluid communication between the first and second containers.
According to another embodiment of the connector, the connector comprises (i) a body including a proximal end with a cavity for receiving and engaging the first container and a distal end having an opening for providing fluid communication with the second container, (ii) at least one resilient retention member for securing the first container to the connector, where the at least one resilient retention finger is positioned within the cavity near the proximal end of the body and is attached to the body via at least two tabs forming a slit therebetween. The at least one resilient retention member is configured to engage a shoulder of the first container, and inhibit removal of the first container from the connector after a distal end of the first container is inserted a predetermined distance into the cavity.
In another embodiment, the at least two tabs attaching the at least one resilient retention finger to the body of the connector have a thickness less than that of the at least one retention member. In such an embodiment, removal of the first container from the connector may cause at least one of the at least two tabs to break. In another example, the force required to engage the first container and the connector is between 10-20 lbf.
According to one embodiment of the method, the method comprises (i) providing a system in accordance with one of the above-described embodiments, (ii) connecting the first and second containers to the connector, (iii) removing the removable sealing member by externally manipulating the second container, and (iv) intermixing the first and second substances.
In another embodiment, the second container may be connected to the connector before the first container is connected to the connector. However, in another example the first container may be connected to the connector before the second container is connected to the connector.
And it is expressly contemplated that any alternative, permutation, or other variation or feature of any disclosed embodiment may apply to any other embodiment, to the extent that alternative, permutation, or other variation or feature would be consistent and compatible with such other embodiment. In other words, disclosure of a given alternative, permutation, or other variation or feature of the system, connector, method, and/or any other component or step, or collection of components and steps in connection with a given embodiment thereof is in no way intended to be limited to that given embodiment. Furthermore, it should be noted that the above overview is intended to be illustrative and not limiting.
The system and corresponding method disclosed herein allow a user (e.g., a pharmacist or other healthcare worker) to intermix at least two substances from two separate containers while maintaining sterility and preventing unwanted release of the substances into the environment.
The type, size, shape, and material of the containers are not critical features of the invention. Nor are the containers' contents. The invention is appropriate for all types and sizes of containers, and for all type of contents. As described more fully below, the containers should have features that allow for sealing engagement between the connector and the containers to provide an airtight and sterile fluid communication between the containers.
A. Structure
An exemplary embodiment of the first container 102 shown in
The neck portion 114 includes a shoulder 117 that circumscribes the container opening 118. A resilient, pierceable seal 120 (e.g., a pharmaceutical vial stopper) prevents discharge of the first substance 104 from the container. Other examples of the first container 102 may include a different type of seal, such as a septum. The first substance 104 may be any liquid or solid substance, and generally includes medicaments that are intended to be dissolved or diluted before delivery to a patient, for example, through intravenous or subcutaneous delivery.
Many medicaments for intravenous delivery are provided in a dried form (e.g., lyophilized or spray-dried) in a standard vial. When the connector 110 is used to connect the vial 102 to a diluent container 106, fluid communication can be established between the vial and the diluent container. Diluent can enter the vial and dissolve the dried contents, which can then be transferred to the diluent container prior to administration to the patient.
Although in this example both securing mechanisms 136, 140 completely circumscribe the opening 128, in other examples, one or both of the securing mechanisms may only partially circumscribe the opening. Moreover, the securing mechanisms 136, 140 can have alternative configurations. For example, it is possible to incorporate ratchet teeth 140 into the form of threads 136 so as to provide both functionalities in a single structure. Alternative securing mechanisms that allow the vial 102 to be secured to receiving port 124 of second container 106 in a manner that substantially prevents subsequent detachment of the vial 102 are possible using known techniques and structures.
When the second container 106 is secured to the connector 110, the threads 136 in the receiving port 124 of the second container 106 engage complementary threads 177 on the connector 110 as described below, and the ratchet teeth 140 allow the threaded engagement, but not the disengagement of the threads 136, 177. In addition to threads and ratchet teeth, other types of securing mechanisms may be used for ensuring that the connector 110, once engaged with the second container 106, cannot be removed. This allows for a permanent and sterile communication between the connector 110 and the second container 106, and prevents accidental discharge of the contents 108 of the second container 106 (and the contents 104 of the first container 102, once connected) into the environment, for example, due to an operator accidentally unscrewing the connector 110 from the second container 106.
The receiving port 124 also includes a removable sealing member 130 positioned partially within the receiving port 124 and partially within an interior chamber defined by body 122. When the removable sealing member 130 is engaged (e.g., by a press or snap fit) with the receiving port 124, as depicted in
Second substance 108 can be a variety of known substances, but in the embodiments described herein, second substance 108 is an IV-therapy fluid diluent known in the art (e.g., 0.9% Sodium Chloride). In alternative embodiments, second container 106 can be empty, and its contents are derived from the first container 102 (after connection with the first container 102 as described herein) or derived from an external source through a separate port or opening in second container 106.
The connector body 154 generally comprises three portions, a proximal portion 184, a middle portion 186, and a distal portion 188. In the exemplary embodiments of
To facilitate securement of the connector 110 to the second container 106, the threads 177 are complementary to the threads 136 in the receiving port 124 of the second container 106. Additionally, the one-way ratchet teeth 182 are complementary to the one-way ratchet teeth 140 in the receiving port 124 of the second container 106. Engagement of the one-way ratchet teeth 140, 182 prevents the connector 110 from backing out once it has been threadably attached to the second container 106. In this example, the axial displacement between the threads 177 and the ratchet teeth 182 is such that during securement of the connector 110 to the second container 106, threaded engagement precedes ratchet engagement, however, in other embodiments, threaded and ratchet-teeth engagement may occur simultaneously. Herein, the threads 177 and ratchet teeth 182 of the connector 110 are collectively referred to as “securing mechanisms” of the connector. In various embodiments, only one of the securing mechanisms is used.
In an alternative configuration, ratchet teeth 182 can be formed as part of threads 177. In such a configuration, threads 177 and ratchet teeth 182 would be complementary to a similar configuration for threads 136 and ratchet teeth 140 in order to provide the desired securement of connector 110 to second container 106.
As best shown in the cross-sectional views of the connector 110 illustrated in
The fingers 150 are configured to prevent removal of the first container 102 from the connector 110 after the distal end 116 of the first container 102 is inserted a predetermined distance into the cavity 148. As with the engagement between the connector 110 and second container 106, with a sufficient amount of force, the first container 104 can be separated from the connector 110 but not without visibly damaging the connector and/or first container. The predetermined distance required to engage the first container 104 with the connector 110 corresponds to the amount of insertion required for the fingers 150 to engage shoulder 117 of the first container 102. By preventing removal of the first container 102 from the connector 110, drug tampering and contamination, and accidental discharge of the substances 104, 108 caused by container-connector disengagement, is prevented.
In another embodiment of the retention fingers 150 shown in
The vertical (or axial oriented) thickness of each tab 208 may be equal to or less than the thickness of the retention finger 150. In an embodiment utilizing tabs 208 that are thinner than the retention fingers 150, the insertion force required to engage the first container 104 and the connector 110 is decreased due to increased flexibility of the fingers 150 at the tabs 208. In addition, the width W1 of the tabs 208 may be minimized to further reduce the insertion force. In one embodiment, the width W1 of the tabs 208 is between 0.1-0.15 inches. In another embodiment the width W1 may be 0.125 inches.
In the embodiment shown in
Moreover, the tab/slit configuration can provide a visual indication in the event that the first container 104 is removed from the connector 110 because in such an event, the tabs 208 attaching the retention fingers 150 to the connector 110 tend to break or fracture, thus inhibiting ill-advised reuse of the connector 110. The geometry of the slits 210, including their width W2 and arc length, may change from that shown in
In another embodiment of the retention fingers 150 shown in
In the embodiment shown in
In addition to preventing removal of the first container 104 from the connector 110, the connector 110 is configured to prevent over-insertion of the first container 104 after it is engaged with the connector 110 via the retention fingers 150. As shown best in the connector illustrated in
To provide fluid communication between the contents of one container and the other, a hollow penetrating member 156 that is radially inwardly (or laterally) offset from the fingers 150 is provided. The penetrating member 156 extends in the proximal direction 158 from a generally centrally-located (or substantially axial) position within the cavity 148 to a position near the proximal end 152 of the connector body 110. The penetrating member may extend beyond the proximal end 152 of the connector. The penetrating member 156 is configured to pierce the seal 120 of the first container 102. Accordingly, the proximal end 160 of the penetrating member 156 is pointed. As first container 102 is moved into cavity 148, penetrating member 156 penetrates seal 120 of the first container, and when first container 102 has been inserted the predetermined distance within cavity 148 (i.e., the distance at which fingers 150 engage shoulder 117 of first container 102), penetrating member 156 has fully penetrated seal 120 in order to provide fluid access to contents 104, as described in greater detail below.
In the embodiment depicted in
In the embodiment depicted in
The flow passageway 162 is defined through the penetrating member 156 and fluidly connects with the distal opening 168 of the connector 110, thereby providing fluid communication between the apertures 164, 166 and the distal opening 168. The cross-sectional area of flow passageway 162 is preferably selected to be as large as possible in order minimize flow resistance and maximize flow volume through flow passageway 162. This will minimize the amount of force or “milking” necessary in order to move fluids into and out of vial 102.
In a further embodiment of the connector 110 shown in
As shown in
Prior to securing the first or second containers 102, 106 to the connector 110, it is desirable to maintain sterility of the connector by preventing contamination of the connector and its various components. Therefore, in addition to the removable plug 200 (which is not present in all embodiments of the connector 110), the connector 110 may include a cap 170 (see
Cap 170 is provided in order to maintain sterility of penetrating member 156 prior to use and must be completely removed from penetrating member 156 before a vial 102 can be inserted into the connector. Proximal end cap 172 is provided in order to protect penetrating member 156 and to prevent the ingress of contaminants (including dust) into the interior of connector body 154 prior to use. Proximal end cap 172 can be a separate and completely detachable structure or it can be hingedly attached (e.g., via a living hinge 173, a flexible band, a pin joint, etc.) to connector body 154 such that it can be swung open. In addition, proximal end cap 172 can be injection-molded with connector body 154 such that proximal end cap 172 is frangibly connected to connector body 154 prior to use. However, the frangible connection between cap 172 and connector body 154 must allow for easy removal of cap 172 from connector body 154 in order for a user to remove the cap prior to use.
The distal portion 188 of the connector 110 may also be provided with an end cap 176. End cap 176 may be threaded for engagement with threads 177 of the connector 110. Additionally or alternatively, end cap 176 may be configured for a snap and/or press fit attachment to the distal portion 188 of the connector 110. In other examples, the distal end 174 of the connector 110 may be provided with a different type of cover. For instance, the distal end 174 of the connector 110 may come with a seal or septum that can be pealed off or pierced by the user prior to use.
As best shown in
Both of the end caps 172, 176 may be provided with anti-tamper features to prevent inadvertent removal. For example, each end cap 172, 176 may be attached to the connector body 154 via a frangible feature such as a post or weld, or a snap fit known in the art. In an embodiment using a frangible feature such as a post or weld, the post or weld would need to be fractured in order to remove the end cap. Such an embodiment provides tactile and visual feedback to the user that the end cap has been removed. In an embodiment using a snap fit connection, the user must disengage the snap fit which also provides tactile feedback.
The connector body 154 may be a single unitary part or may be constructed from more than one part. For instance, as shown best in
B. Operation
The system 100 allows a user to attach the first container 102 to the second container 106 with the ability to establish fluid communication between the containers at a subsequent time. This is important because of the limited shelf-life of some substances once they have been mixed or reconstituted with another substance. Therefore, the system 100 allows, for example, a pharmacist to securely connect the first container 102 to the second container 106 in a permanent manner without establishing fluid communication between the containers. A nurse or other practitioner can then establish fluid communication between the containers at a patient's bedside by removing the sealing member 130 from the receiving port 124 the second container 106.
To secure the second container 106 to the connector 110, the user inserts the distal threaded portion 188 of the connector 110 into the receiving port 124 of the second container 106. Once contact is made between the complementary threads 136, 177 of the connector 110 and second container 106, the user rotates the connector in the clockwise direction, thereby screwing the connector to the second container.
After the distal threaded portion of the connector 110 is screwed a predetermined axial distance into the receiving port 124 of the second container 106, the complementary one-way ratchet teeth 140, 182 of the connector and second container begin to engage. The user continues to screw the connector 110 into the second container 106 until further axial displacement is no longer possible without damaging the threads and/or ratchet teeth of the container and/or connector. At a threshold axial engagement of the ratchet teeth 140, 182, the connector 110 is prevented from backing-out of the receiving port 124. Where the connector 110 is provided with a removable plug 200, the removable plug 200 of the connector preferably simultaneously advances onto and engages the plug removing feature 206 of the removable sealing member 130 while the user screws the connector 110 into the second container 106 (see
The radially inward and distally extending configuration of the fingers 150 centers the first container 102 in the connector 110. Once the fingers 150 latch onto the shoulder 117 of the first container 102 (i.e., when the proximal surface of the shoulder passes the distal surface or edge of the finger), removal of the first container 102 from the connector 110 is prevented or at least made very difficult without causing damage to the first 102 container and/or connector 110.
After first container 102 has been connected to connector 110, fluid communication between the first and second containers 102, 106 (via the connector 110) is prevented by the removable sealing member 130 alone, or by the removable sealing member 130 in combination with removable plug 200, depending on whether the connector 110 includes a removable plug 200.
Where it is desirable for the user to connect the connector 110 to the second container 106 first, the various protective caps 170, 172, 176 may be provided with numbers that correspond to the order of steps that the user is supposed to take. For example, the distal end cap 176 may be provided with the number 1, which signals to the user that the distal end cap 176 should be removed first and then the second container 106 should be connected to the connector 110. The proximal end cap 172 may be provided with the number 2, which signals to the user that the proximal end cap 172 should be removed second. Finally, the penetrating member cap 170 may be provided with the number 3, which signals to the user to remove the cap 170 third. The first container 104 can now be connected to the connector 110 and intermixing can ensue.
In the case where the connector 110 does not include a removable plug 200, to remove the sealing member 130, the user externally manipulates the flexible walls of second container 106 until the user can grasp the flange 144 of the sealing member. Once the user can grasp the flange 144, the user pulls, pushes, or flips down (i.e., in the distal direction 142) on the flange until the force is great enough to overcome the force securing the sealing member 130 to the receiving port 124, thereby disengaging the sealing member from the receiving port. If the connector 110 includes the removable plug 200 as shown in
Various embodiments of the system (including its components) and corresponding method for intermixing at least two substances have been described above. Those skilled in the art will understand, however, that changes and modifications may be made to those embodiments without departing from the scope of the claims.
This application is a continuation of U.S. application Ser. No. 13/328,983, filed Dec. 16, 2011, which claims the benefit of U.S. Provisional Application No. 61/424,263, filed Dec. 17, 2010.
Number | Name | Date | Kind |
---|---|---|---|
2176923 | Nitardy | Oct 1939 | A |
2372181 | Barr | Mar 1945 | A |
3290017 | Davies et al. | Dec 1966 | A |
3464414 | Sponnoble | Sep 1969 | A |
3532254 | Burke et al. | Oct 1970 | A |
3857392 | Ogle | Dec 1974 | A |
3872992 | Larson | Mar 1975 | A |
4089432 | Crankshaw et al. | May 1978 | A |
4102451 | Clarke et al. | Jul 1978 | A |
4123091 | Cosentino et al. | Oct 1978 | A |
4185747 | Goncalves | Jan 1980 | A |
4194640 | Crankshaw et al. | Mar 1980 | A |
4226334 | Weiler et al. | Oct 1980 | A |
4333505 | Jones et al. | Jun 1982 | A |
4394922 | Wimmer | Jul 1983 | A |
4444330 | Kasai et al. | Apr 1984 | A |
4458811 | Wilkinson | Jul 1984 | A |
4488656 | Fukuoka et al. | Dec 1984 | A |
4526572 | Donnan et al. | Jul 1985 | A |
4544074 | Evans | Oct 1985 | A |
4610684 | Knox et al. | Sep 1986 | A |
4614267 | Larkin | Sep 1986 | A |
4614515 | Tripp et al. | Sep 1986 | A |
4703864 | Larkin et al. | Nov 1987 | A |
4757911 | Larkin et al. | Jul 1988 | A |
4759756 | Forman | Jul 1988 | A |
4770445 | Steer et al. | Sep 1988 | A |
4781679 | Larkin | Nov 1988 | A |
4784259 | Grabenkort | Nov 1988 | A |
4784658 | Grabenkort | Nov 1988 | A |
4871354 | Conn et al. | Oct 1989 | A |
4871654 | Vanmaaele et al. | Oct 1989 | A |
4936445 | Grabenkort | Jun 1990 | A |
4936841 | Aoki | Jun 1990 | A |
4948000 | Grabenkort | Aug 1990 | A |
4963441 | Takai et al. | Oct 1990 | A |
4998671 | Leifheit | Mar 1991 | A |
5060812 | Ogle, II | Oct 1991 | A |
5064059 | Ziegler et al. | Nov 1991 | A |
5066280 | Braithwaite | Nov 1991 | A |
5066286 | Ryan | Nov 1991 | A |
5088994 | Porat et al. | Feb 1992 | A |
5102408 | Hamacher | Apr 1992 | A |
5139483 | Ryan | Aug 1992 | A |
5176526 | Hillbish et al. | Jan 1993 | A |
5195994 | Dieringer | Mar 1993 | A |
5222486 | Vaughn | Jun 1993 | A |
5290222 | Feng et al. | Mar 1994 | A |
5292308 | Ryan | Mar 1994 | A |
5332399 | Grabenkort et al. | Jul 1994 | A |
5335773 | Haber et al. | Aug 1994 | A |
5350372 | Ikeda | Sep 1994 | A |
5358501 | Meyer | Oct 1994 | A |
5380315 | Isono | Jan 1995 | A |
5409141 | Kikuchi et al. | Apr 1995 | A |
5423793 | Isono | Jun 1995 | A |
5462526 | Barney et al. | Oct 1995 | A |
5478337 | Okamoto et al. | Dec 1995 | A |
5526853 | McPhee | Jun 1996 | A |
5527580 | Ikeda et al. | Jun 1996 | A |
5545152 | Funderburk et al. | Aug 1996 | A |
5620427 | Werschmidt et al. | Apr 1997 | A |
5785701 | Sams et al. | Jul 1998 | A |
5855568 | Battiato et al. | Jan 1999 | A |
5928213 | Barney et al. | Jul 1999 | A |
5944709 | Barney et al. | Aug 1999 | A |
5947954 | Bonaldo | Sep 1999 | A |
5989237 | Fowles et al. | Nov 1999 | A |
6004297 | Steenfeldt-Jensen et al. | Dec 1999 | A |
6063068 | Fowles et al. | May 2000 | A |
6071270 | Fowles et al. | Jun 2000 | A |
6096024 | Graves et al. | Aug 2000 | A |
6113583 | Fowles et al. | Sep 2000 | A |
6159192 | Fowles et al. | Dec 2000 | A |
6203535 | Barney et al. | Mar 2001 | B1 |
6258078 | Thilly | Jul 2001 | B1 |
6382442 | Thibault et al. | May 2002 | B1 |
6413242 | Michel et al. | Jul 2002 | B1 |
6610040 | Fowles et al. | Aug 2003 | B1 |
6729370 | Norton et al. | May 2004 | B2 |
6846305 | Smith et al. | Jan 2005 | B2 |
6874522 | Anderson et al. | Apr 2005 | B2 |
6910573 | Deans | Jun 2005 | B2 |
6913595 | Mastorakis | Jul 2005 | B2 |
6957745 | Thibault et al. | Oct 2005 | B2 |
6962321 | Savage et al. | Nov 2005 | B1 |
7115117 | Shiraishi et al. | Oct 2006 | B2 |
7316679 | Bierman | Jan 2008 | B2 |
7347458 | Rome et al. | Mar 2008 | B2 |
7473246 | Vancaillie et al. | Jan 2009 | B2 |
7497484 | Ziman | Mar 2009 | B2 |
7540863 | Haindl | Jun 2009 | B2 |
7544191 | Peluso et al. | Jun 2009 | B2 |
7600515 | Matlock | Oct 2009 | B2 |
7615041 | Sullivan et al. | Nov 2009 | B2 |
7862539 | Knight | Jan 2011 | B2 |
7938815 | Shoji et al. | May 2011 | B2 |
7998134 | Fangrow et al. | Aug 2011 | B2 |
8075545 | Moy et al. | Dec 2011 | B2 |
8162013 | Rosenquist et al. | Apr 2012 | B2 |
8216207 | Moy et al. | Jul 2012 | B2 |
8221382 | Moy et al. | Jul 2012 | B2 |
8241265 | Moy et al. | Aug 2012 | B2 |
8512309 | Shemesh et al. | Aug 2013 | B2 |
8721612 | Domkowski | May 2014 | B2 |
8801689 | Moy et al. | Aug 2014 | B2 |
20020082581 | Di Giovanni et al. | Jun 2002 | A1 |
20030105448 | Shiraishi et al. | Jun 2003 | A1 |
20030106610 | Roos et al. | Jun 2003 | A1 |
20030187420 | Akerlund et al. | Oct 2003 | A1 |
20030201641 | Guest | Oct 2003 | A1 |
20040186457 | Truitt et al. | Sep 2004 | A1 |
20040201216 | Segal et al. | Oct 2004 | A1 |
20050015075 | Wright et al. | Jan 2005 | A1 |
20050045669 | Thunberg et al. | Mar 2005 | A1 |
20050055008 | Paradis et al. | Mar 2005 | A1 |
20060030832 | Niedospial et al. | Feb 2006 | A1 |
20060282061 | Domkowski et al. | Dec 2006 | A1 |
20070088315 | Haindl | Apr 2007 | A1 |
20070102393 | Colin et al. | May 2007 | A1 |
20090032489 | Moy et al. | Feb 2009 | A1 |
20090036861 | Moy et al. | Feb 2009 | A1 |
20090036864 | Moy et al. | Feb 2009 | A1 |
20090036865 | Moy et al. | Feb 2009 | A1 |
20090036866 | Moy et al. | Feb 2009 | A1 |
20090069783 | Ellstrom et al. | Mar 2009 | A1 |
20090259197 | Christiansen | Oct 2009 | A1 |
20090270832 | Vancaillie | Oct 2009 | A1 |
20100148500 | Uehara et al. | Jun 2010 | A1 |
20100152669 | Rosenquist | Jun 2010 | A1 |
20100211019 | Greco | Aug 2010 | A1 |
20100241088 | Ranalletta | Sep 2010 | A1 |
20110015580 | Stroup | Jan 2011 | A1 |
20110125128 | Nord et al. | May 2011 | A1 |
20110137294 | Calimeri et al. | Jun 2011 | A1 |
20110193004 | Lahaye | Aug 2011 | A1 |
20120136317 | Teucher et al. | May 2012 | A1 |
20120330267 | Domkowski et al. | Dec 2012 | A1 |
20130102990 | Domkowski | Apr 2013 | A1 |
20130102991 | Domkowski | Apr 2013 | A1 |
20130102992 | Domkowski | Apr 2013 | A1 |
20130199643 | Domkowski | Aug 2013 | A1 |
20140001063 | Moy et al. | Jan 2014 | A1 |
20140005629 | Moy et al. | Jan 2014 | A1 |
Number | Date | Country |
---|---|---|
297 21 872 | Mar 1998 | DE |
0 335 378 | Oct 1989 | EP |
0 633 038 | Jan 1995 | EP |
0 503 867 | Feb 1997 | EP |
2931363 | Nov 2009 | FR |
2952873 | May 2011 | FR |
1419061 | Dec 1975 | GB |
8243171 | Sep 1996 | JP |
10024088 | Jan 1998 | JP |
2002017871 | Jan 2002 | JP |
2003200977 | Jul 2003 | JP |
2007236567 | Sep 2007 | JP |
2007295998 | Nov 2007 | JP |
9814163 | Apr 1998 | WO |
2008115102 | Sep 1998 | WO |
9844257 | Oct 1998 | WO |
0066921 | Nov 2000 | WO |
0123026 | Apr 2001 | WO |
2009024807 | Feb 2009 | WO |
2009035383 | Mar 2009 | WO |
2010069361 | Jun 2010 | WO |
Entry |
---|
Extended European Search Report for EP10160160.7 including concise summary of DE 297 21 872 (Oct. 6, 2010). |
“Special 510(k) Premarket Notification—addEASE 20 mm Binary Connector with 17 Ga. Needle,” B. Braun Medical, Inc., Mar. 27, 2009. Describing the B. Braun add EASE Connector. |
“addEASE Binary Connector with 17 Ga. Needle,” B. Braun Medical Inc., 2011. Describing the B. Braun addEASE Connector. |
“B. Braun addEASE Binary Connector,” Medical Device Recalls, U.S. Food and Drug Administration, Jun. 24, 2010. Describing the B. Braun addEASE Connector. |
Number | Date | Country | |
---|---|---|---|
20140246342 A1 | Sep 2014 | US |
Number | Date | Country | |
---|---|---|---|
61424263 | Dec 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13328983 | Dec 2011 | US |
Child | 14274441 | US |